Annegien Broeks

机构：The Netherlands Cancer Institute, Oncode Institute, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital · ORCID：0000-0002-8699-5058

发表论文 444 篇 · 总被引 43607 次 · h-index 81

代表论文

Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial (2025 · Nature Medicine · 被引 12)
Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade Therapy (2025 · Cancer Discovery · 被引 7)
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial (2026 · Nature Medicine · 被引 6)
Clinical, pathological and molecular characteristics of patients with disease recurrence despite pathologic response to neoadjuvant ipilimumab plus nivolumab in stage III melanoma (2025 · Communications Medicine · 被引 5)
Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases (2025 · The Breast · 被引 1)
Spatial structures of tumor and immune cells shape outcomes in ER⁺HER2⁻ and triple-negative breast cancer (2026 · npj Breast Cancer)